Funabashi, Japan

Ryoji Matsui


Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 41(Granted Patents)


Location History:

  • Funabashi, JP (1980)
  • Ichikawa, JP (1987)

Company Filing History:


Years Active: 1980-1987

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ryoji Matsui: Innovator in Pharmaceutical Compounds

Introduction

Ryoji Matsui is a notable inventor based in Funabashi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds. With a total of three patents to his name, Matsui's work focuses on developing agents that have therapeutic applications.

Latest Patents

Matsui's latest patents include a novel amidine compound, which is characterized by its formula and is recognized for its powerful anti-trypsin, anti-plasmin, anti-kallikrein, and anti-thrombin properties. These compounds are also noted for their effectiveness as anti-complement agents. Another significant patent involves amino- or guanidino-1,2,3,4-tetrahydro-1-naphthoic esters, which exhibit inhibitory activity on proteolytic enzymes. This makes them useful in treating diseases caused by such enzymes.

Career Highlights

Matsui is currently associated with Torii & Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating compounds that address various medical conditions, showcasing his commitment to innovation in the pharmaceutical industry.

Collaborations

Matsui has collaborated with notable colleagues, including Setsuro Fujii and Yojiro Sakurai. These partnerships have contributed to the success of his projects and the advancement of their shared goals in pharmaceutical research.

Conclusion

Ryoji Matsui stands out as a dedicated inventor whose work in pharmaceutical compounds has the potential to impact medical treatments significantly. His innovative spirit and collaborative efforts continue to drive advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…